2026-11-15 · 2026-11 / week-3

REalloys' Army term sheet does not bind a buyer for its planned magnets

REalloys' Army term sheet does not bind a buyer for its planned magnets

Summary: REalloys reported $0.413 million of Q3 revenue and $23.4 million of nine-month operating cash use. Its Nov. 13 filing shows $106.4 million of unrestricted cash, but also $56.0 million of SRC commitments as of Sept. 30, an $8.1 million pre-operation working-capital estimate and a $10 million R&D program through 2027. The Army term sheet is non-binding and does not require the Army to buy output. A separate definitive Tanbreez agreement is a feedstock purchase by REalloys, not a customer order for planned magnets. ALOY closed at $5.71 after falling 9.65% on Nov. 13. The strategic story is real; the customer-revenue bridge is not. Reject / no trade.

Opportunity Ranking

This ranks the value of a fresh no-trade screen, not executable opportunities. SPY was the liquid U.S. control: $754.37 at the Nov. 13 regular close, down 0.36%.

Rank Candidate Direction Mispricing Evidence Freshness Catalyst Window Positioning 10/5 Status Tradeability Main Rejection Risk
1 REalloys (ALOY) Long Strategic supply-chain optionality versus no binding Army lease, no committed buyer for planned magnets and a long production path Nov. 13 10-Q and release; Nov. 13 close Army EUL negotiations; staged SRC production in 2027-28; magnet target by 2030 2.63M shares traded, but current ownership, short and options data are unknown Reject: flat base; downside beyond the recent low is unbounded Active Nasdaq common stock; spread, depth, venue and exit data not verified Non-binding government lease, project costs and no customer contracts for planned magnets
2 Intuitive Machines (LUNR) Long Record $269M Q3 revenue and $1.87B backlog versus negative nine-month free cash flow and a sharp recent rally Nov. 12 Q3 release and Nov. 13 10-Q Mission delivery, product margins and cash conversion 11.53M shares traded Nov. 13; direct positioning not checked Reject: no evidenced +10% base with bounded downside High reported volume, but no live exit review Q3 free cash flow was positive; nine-month free cash flow was -$112.3M, and backlog includes acquired contracts
3 Tempest Therapeutics (TPST) Long Early in-vivo CAR-T progress versus financing dependence and a Nasdaq bid-price deficiency Nov. 13 Q3 release and 10-Q; Nov. 13 close Phase 1 follow-up and financing 153,516 shares traded; current positioning unknown Reject: no current revenue, adverse path and dilution are not bounded Thin tape; spread, depth and exit capacity unknown $0.9M quarter-end cash, going-concern doubt and equity-line capacity that is not cash

Selected opportunity: ALOY as the most useful current no-trade screen, not as the best executable long.

Why this one now: The Nov. 13 10-Q supplies both sides of the story: an Army term sheet for a possible 200-acre facility and a clearer statement of the conditions, spending and schedule needed to turn that option into operations. The share-price decline was 9.65% on Nov. 13 according to S&P Global close history. The disagreement is between strategic access to future production and evidence of a funded customer business.

What should surprise the reader: REalloys has a definitive 15-year Tanbreez agreement for 15% of Phase 1 production. It buys feedstock for REalloys. It does not require anyone to buy the metals or magnets REalloys plans to make.

Why ALOY Ranks First for Research, Not as a Trade

There is no prior standalone ALOY article or signal in the archive. The Q3 filing and release add fresh evidence beyond the Nov. 3 Army term-sheet announcement: post-quarter cash, share count, operating cash use, SRC commitments and the legal status of the proposed lease.

LUNR and TPST are materially different comparisons. LUNR's Nov. 12 release recorded positive Q3 free cash flow, but its Nov. 13 10-Q shows deeply negative nine-month free cash flow and backlog that includes acquired work. TPST's fresh Q3 filing combines early clinical data with a $0.9 million cash balance and explicit going-concern doubt. Neither improves the ALOY case enough to clear 10/5.

Why It Could Move More Than 5% Soon

StockAnalysis / S&P Global reports ALOY fell 9.65% on Nov. 13, trading 2,625,596 shares versus 1,427,578 the prior session. The move clears the Desk's greater-than-5% discovery filter; it does not show a favorable expected return or explain the full decline.

The Army EUL negotiation has no verified near-term decision date. The term sheet allows either party to terminate if conditions remain unmet after 18 months. The next disclosed operating milestones are expected from SRC in 2027 and 2028. A 20-session price map is market context, not a catalyst forecast.

10/5 Asymmetry Gate

The reference-only 20-session map gives a flat base case. It cannot support a base move of at least +10%. The lowest observed marker is only 4.6% below the close, but that intraday low is not a downside boundary. A project delay, financing gap, failed lease or absence of customers could take the stock lower. There is no evidence that credible adverse risk is bounded to -5%.

10/5 status: Reject / no trade. The base fails +10%; downside is not bounded; no verified executable entry or costs exist.

The Setup

Fact: The Q3 release reports net revenue of $0.413 million, compared with $0.186 million a year earlier. Net loss was $30.5 million, including $25.3 million of non-cash stock compensation. Nine-month operating cash use was $23.4 million and investing cash use was $8.5 million. Net cash provided by financing was $145.3 million, primarily from 2026 equity offerings.

Fact: The filing reports $116.2 million of cash at Sept. 30 and approximately $106.4 million of unrestricted cash at the Nov. 13 statement issuance date. It reports 69,666,671 common shares outstanding on Nov. 8, versus 49,293,557 at Dec. 31, 2025. The basic share count rose about 41.3%. The current count after Nov. 8 was not separately reported.

Fact: The 10-Q describes an Army term sheet for a potential rare-earth processing facility at Tooele Army Depot. Except for customary provisions, it is non-binding. Neither side is required to enter a definitive lease. A lease would require, among other things, agreed rent, Army acceptance of the development plan, environmental reviews, permits, project financing and Army approvals. The Army would have a right of first offer on output, without an obligation to purchase it.

Fact: The definitive Tanbreez agreement is a purchase by REalloys of feedstock equal to 15% of that project's Phase 1 monthly production, subject to qualification and the mine beginning commercial delivery. It is not a downstream sales agreement. The 10-Q says REalloys has no definitive customer offtake or sales agreement for planned magnet output, except existing contract work at its Euclid facility.

Inference: Feedstock access and an Army lease could support an integrated supply chain. They do not establish profitable output sales, project returns or a common-share valuation today.

The Market Price

StockAnalysis, citing S&P Global Market Intelligence, reports ALOY at $5.71 at the Nov. 13 regular close, down $0.61 or 9.65%, with a $5.45-$6.15 range and 2,625,596 shares traded. The $5.45 intraday low is also the source's 52-week low. The $26.90 52-week high is not a fair-value anchor.

The 10-Q reports 69,666,671 shares outstanding on Nov. 8; multiplied by the $5.71 close, this gives an approximately $397.8 million basic equity-value proxy. This uses a five-day-old share count and excludes preferred stock, future awards and other potentially dilutive claims. It is not enterprise value. I do not have sufficient reliable data to quantify the market-implied probability of a definitive EUL or profitable magnet production.

The Mispricing

The optimistic case is strategic scarcity: U.S. sourcing rules, no-China policy and defense demand could make qualified dysprosium, terbium and neodymium more valuable. The company also has a definitive feedstock agreement, access to SRC capacity and more than $100 million of unrestricted cash.

The countercase is that the price still reflects future capacity before commercial product sales are material. Q3 revenue was under half a million dollars. The Army has not signed a definitive lease, and the term sheet does not promise purchases. The separate 15-year Tanbreez agreement secures input supply only after the mine, deliveries and qualification. No independent value model or consensus forecast was verified, so a 78.8% fall from the year's high is not evidence by itself that ALOY is cheap.

The Positioning

Observed: Volume rose to 2.63 million shares on Nov. 13 from 1.43 million the prior session, as the share price fell 9.65%.

Unknown: Current holder concentration, short interest, borrow, options, dealer exposure, institutional flows, spread, depth, venue quality, volume quality and realistic exit capacity were not verified. The volume spike does not establish forced selling or capitulation. Positioning score: 2/5.

The Catalyst

Event Timing Test
Definitive Tooele EUL No execution date verified; term sheet allows termination if conditions are not met within 18 months Confirm signed lease, agreed rent, project plan, environmental review, permits, financing and Army determinations. The current term sheet does not bind a buyer.
NdPr metal through SRC Company expects capability beginning in Q1 2027 Verify output, quality qualification, customer delivery and collected revenue.
Heavy rare-earth metallization facility Commissioning target Q1 2028; initial operations targeted H1 2028 Verify construction, permits, capex, yields, feedstock, product qualification and actual costs.
Initial U.S. magnet production Company target no later than 2030 Require binding customer volumes and pricing, validated production economics and funded capacity.

The 10-Q also says REalloys requested an extension of a non-binding EXIM letter of interest for up to $200 million; the request remained under review in the 10-Q. That letter is not committed project financing. The company says U.S. procurement restrictions begin Jan. 1, 2027, but policy does not guarantee that REalloys will qualify, produce or win orders.

The Payoff

The strongest long path is a staged conversion: SRC metal capability in 2027, heavy rare-earth operations in 2028, and a U.S. magnet line by 2030. The company has cash, no material debt and two potential supply-side supports: the SRC relationship and the Tanbreez feedstock agreement.

The downside is that the chain has several independent gates. The Army lease is unexecuted. Tanbreez is not in production. The offtake is conditioned on output and qualification. The company bears project, permitting, site and operating costs; prices, recoveries, customer volumes, margins and return on capital are not established. The current cash balance can fund some milestones but does not prove the final plant will earn an acceptable return.

Price Target and Probability Map

Reference-only 20-session map through Dec. 14, 2026. The levels below are recent market markers, not fair-value targets or downside bounds. Probabilities are subjective judgments, not observed frequencies.

Scenario Probability Target / Level Return / Payoff Horizon Conditions Evidence Quality
Top Case 15% $7.01 +22.8% Through Dec. 14, 2026 Retest of the Nov. 11 intraday high as investors assign more value to the announced project path Low
Base Case 55% $5.71 0.0% Same Price remains near the latest close while the EUL, funding and customer tests remain open Low
Bottom Case 30% $5.45 -4.6% to the observed low marker Same Retest of the Nov. 13 low; losses below that level are not capped Low
Invalidation n/a The EUL is signed with financeable terms, commercial customers commit to planned magnet output, and filed cash/production data support unit economics No position exists to invalidate Before reconsideration Rebuild the value bridge; this Reject is not an open position Medium

Probability-weighted price marker: $5.83, or +2.0% gross before costs. This is not a responsible estimate of intrinsic value or true expected return because the bottom marker is not a loss boundary and the EUL economics are incomplete.

Current market level and timestamp: $5.71, Nov. 13, 2026, 4:00 p.m. EST regular-session close.

Primary instrument: ALOY common stock, unlevered.

10/5 favorable base move: 0.0% from the reference close.

10/5 credible adverse move: Not bounded. The $5.45 low is only a recent market print; there is no evidence that limits further downside to 5%.

10/5 measurement basis: Reference-only; no verified executable entry.

10/5 status: Reject / no trade.

Confidence: Low. Commercial terms, project financing and customer demand are unresolved; the probabilities are subjective.

The Kill Shot

The strongest counterargument is that REalloys may have enough cash to reach intermediate proof points without another financing. The company says baseline obligations are below liquidity, the $106.4 million unrestricted balance was reported on Nov. 13, and the company has near-term plans to produce NdPr metal through SRC. A 15-year Tanbreez agreement provides a defined source of HREE concentrate if the mine begins production and the material qualifies.

That does not validate the 2030 magnet economics. The feedstock agreement makes REalloys a buyer. It does not make the Army or a downstream customer a buyer of REalloys magnets. The Army term sheet gives the Army only a right of first offer and leaves rent and participation terms unagreed. The 10-Q says no definitive customer offtake agreement exists for planned magnet output, apart from existing Euclid contract work.

Load-bearing assumption: The company must convert a staged, capital-intensive supply chain into qualified products with profitable customer contracts before cash and equity funding are consumed.

What Could Go Wrong

  • The Army could decline the lease, or the parties could fail to agree on rent, development terms, environmental reviews, permits or financing.
  • The Tanbreez mine could delay its own production, or its concentrate could fail qualification and timing needs.
  • SRC milestones, the pre-operation working-capital payment, R&D and public-company costs could consume cash faster than milestones generate revenue.
  • NdPr, dysprosium or terbium prices could fall, or processed product costs could exceed customer pricing.
  • Existing contract work at Euclid may not scale into meaningful customer orders.
  • Equity issuance, share-based compensation or a future project financing could dilute current holders. The stock is near a reported 52-week low, but that does not create a floor.

What Would Prove This Wrong

A definitive Army EUL with agreed rent and funded project costs, qualified SRC output, recurring customer orders for processed metals or magnets, and positive cash economics would weaken this Reject. A signed feedstock supply agreement alone would not.

The cheapest next test is the next filed update on the Army EUL and SRC: verify what has been signed, what remains conditional, total cash committed and spent, qualified output, customer shipments, contract pricing and cash receipts. If the company reports only progress milestones, keep the conversion thesis unproven.

Risk Audit

  • Revenue: Q3 sales were $0.413 million; nine-month revenue was $1.9 million. Sales are not yet a meaningful test of the planned integrated platform.
  • Cash: Unrestricted cash fell from $116.2 million at Sept. 30 to about $106.4 million at Nov. 13 issuance. Nine-month operating and investing cash uses totaled $32.0 million; financing provided $145.3 million, mainly from share offerings.
  • Commitments: The 10-Q lists $56.0 million of SRC commitments as of Sept. 30, including a $7.2 million milestone paid in October, plus an $8.1 million pre-operation working-capital estimate and $10 million of planned R&D through 2027. These amounts have different dates and scopes; do not simply add them into a cash-runway forecast.
  • Term-sheet status: Army EUL is non-binding except customary provisions. Neither party must execute a lease. The Army has no obligation to buy output.
  • Supply versus sales: Tanbreez supplies feedstock after production and qualification. No definitive customer offtake for planned magnet output was reported.
  • Denominator: Common shares grew from 49.3 million at Dec. 31, 2025 to 69.7 million at Nov. 8, 2026. The company issued common stock for cash and services; the late-November share count is not confirmed.
  • Listing and market: The $5.45 52-week low is not a floor. Current spread, depth, venue, volume quality and exit liquidity were not verified.

Best Trade Strategy

No trade. Keep entry.price null and execution.can_execute false. Do not treat the Army term sheet, policy restrictions, share-price decline or price markers as an order trigger. Reconsider only after a definitive lease, project finance and permits, qualified product, binding customer demand and a current market-structure review. No options, leverage, margin, market orders or price-floor assumptions.

Sources

  1. REalloys Q3 2026 Form 10-Q, filed Nov. 13, 2026.
  2. REalloys Q3 2026 results and project update, Nov. 12, 2026.
  3. REalloys definitive Tanbreez feedstock offtake, May 21, 2026.
  4. ALOY Nov. 13 price and volume history, citing S&P Global Market Intelligence.
  5. Intuitive Machines Q3 2026 results and Nov. 13 Form 10-Q.
  6. LUNR Nov. 13 price history, citing S&P Global Market Intelligence.
  7. Tempest Q3 2026 results and Nov. 13 Form 10-Q.
  8. TPST Nov. 13 price history, citing S&P Global Market Intelligence.
  9. SPY Nov. 13 regular close, citing S&P Global Market Intelligence.

Research Quality Scorecard

Criterion Score Evidence
Market disagreement 4/5 Cash and strategic optionality contrast with no Army purchase obligation or planned-output customers
Evidence base 5/5 Fresh Q3 10-Q, issuer release and current price reference
Positioning and flows 2/5 One-day volume is observed; direct ownership, short and options data are absent
Catalyst path 3/5 Project milestones are observable but mostly 2027-2030; no dated lease decision
Payoff architecture 2/5 Price markers are not fair value; credible downside cannot be bounded
Invalidation discipline 4/5 EUL, permits, qualified output, customer contracts and cash use can be monitored
Differentiated insight 5/5 Separates government land access, feedstock offtake and downstream customer demand
Client value 4/5 Provides a clear no-trade reason and a short falsification list

Total: 29/40. This is a short no-trade screen. Failed base-case economics and unbounded downside force Reject.

Bottom Line

REalloys has cash, a feedstock agreement and a non-binding Army lease term sheet. Those facts support a strategic option, not a completed customer chain. Its 2030 magnet target remains distant, Q3 revenue was $0.413 million and its market price has no evidenced +10% base or -5% downside limit. Reject / no trade.

AI Illustration Prompt

Institutional editorial illustration of a rare-earth supply chain at an Army depot: a draft lease marked “NON-BINDING” on one side, a Tanbreez feedstock railcar feeding a pilot metallization unit in the middle, and an empty customer-order ledger beside a magnet production line labeled “TARGET 2030”; include a cash ledger with “$106.4M unrestricted, Nov. 13” and “$56M SRC commitments, Sept. 30”; restrained graphite, paper white, muted steel blue and one mineral-green accent; no military weapons, no trading screen, no price chart, no claim of purchase; subtle readable “The Mispricing Desk” watermark at lower right.